Abstract:BACKGROUND Non-linear association between serum 25-hydroxyvitamin D [25(OH)D] concentration and all-cause mortality has been widely reported for the general population, but this association has not been quantified for individuals with inflammatory bowel disease (IBD). OBJECTIVES This was to explore the association between serum 25(OH)D and all-cause mortality in individuals with IBD. METHODS We identified 2690 females and 2532 males aged 40-69 with diagnosed IBD at baseline in the UK Biobank. Serum 25(OH)D concentration was measured by direct competitive chemiluminescent immunoassay. The outcome was all-cause mortality, ascertained via the death registry. Cox proportional hazard regression was used to evaluate associations between serum 25(OH)D in quintiles and all-cause mortality among individuals with IBD (Crohn's disease [CD, n = 1760] and ulcerative colitis [UC, n = 3462]). Restricted cubic splines (RCS) were used to investigate potential non-linearity. RESULTS During the mean follow-up period of 11.9 years, 529 deaths (198 in CD and 331 in UC) were documented among 5222 individuals with IBD. Compared with the lowest quintile of serum 25(OH)D, hazard ratios and 95% confidence intervals for the second to the highest quintiles were 0.82 (0.63, 1.06), 0.63 (0.47, 0.83), 0.64 (0.48, 0.85), and 0.74 (0.55, 0.99), respectively. Non-linearity was detected in the dose-response association between serum 25(OH)D concentration and all-cause mortality (P-nonlinearity < 0.001), and 25(OH)D concentrations of 44-78 nmol/L were associated with a 50% lower risk of all-cause mortality (vs. 10 nmol/L). Subgroup analyses showed that the non-linear association mostly applied to females (P-nonlinearity < 0.001 vs 0.080 in males). CONCLUSIONS We observed a non-linear association, mostly applied to the females, between serum 25(OH)D concentrations and all-cause mortality among individuals with IBD. A concentration range of 44-78 nmol/L of 25(OH)D can serve as a starting point for future research to confirm recommended 25(OH)D concentrations for individuals with IBD.

[Association between vitamin D and inflammatory bowel diseases]

Vitamin D, the gut microbiome and inflammatory bowel disease

Vitamin D and the Pathogenesis of Inflammatory Bowel Disease

Vitamin D improves inflammatory bowel disease outcomes: Basic science and clinical review

The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management

Vitamin D Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis

Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases

Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome

Possible Molecular Mechanisms by Which Vitamin D Prevents Inflammatory Bowel Disease and Colitis-associated Colorectal Cancer.

Vitamin D Axis in Inflammatory Bowel Diseases: Role, Current Uses and Future Perspectives

Interplay of Immunity and Vitamin D: Interactions and Implications with Current IBD Therapy

Vitamin D in Ankylosing Spondylitis: Review and Meta-Analysis

The Efficacy of Vitamin D Supplementation for Irritable Bowel Syndrome: a Systematic Review with Meta-Analysis

Mucosal vitamin D signaling in inflammatory bowel disease

Effects of oral vitamin D supplementation on inflammatory bowel disease: a systematic review and meta-analysis

The intestinal vitamin D receptor in inflammatory bowel disease: inverse correlation with inflammation but no relationship with circulating vitamin D status

Association between 25(OH)D Level, Ultraviolet Exposure, Geographical Location, and Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis

Association between vitamin D level and pediatric inflammatory bowel disease: A systematic review and meta-analysis

[Role of vitamin D in pediatric irritable bowel syndrome].

Exploring the Role of Vitamin D and the Vitamin D Receptor in the Composition of the Gut Microbiota

Non-linear Association Between Serum 25-Hydroxyvitamin D and All-cause Mortality in Adults with Inflammatory Bowel Disease in a Prospective Cohort Study.